Dec 31, 2018

ANI Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$57.1M
Previous year: $47.3M
+20.8%
EPS
$1.32
Previous year: $1.08
+22.2%
Gross Profit
$37M
Previous year: $26.8M
+37.8%
Cash and Equivalents
$43M
Previous year: $31.1M
+38.1%
Free Cash Flow
$26.2M
Previous year: $12.4M
+112.2%
Total Assets
$431M
Previous year: $412M
+4.5%

ANI Pharmaceuticals

ANI Pharmaceuticals

ANI Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income